MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
TSX:MDA • CA55293N1096
39.48 CAD
+0.62 (+1.6%)
Last: Feb 26, 2026, 07:00 PM
MDA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 13 industry peers in the Aerospace & Defense industry. MDA has only an average score on both its financial health and profitability. MDA is growing strongly while it is still valued neutral. This is a good combination! These ratings would make MDA suitable for growth investing!
1. Profitability
1.1 Basic Checks
- MDA had positive earnings in the past year.
- In the past year MDA had a positive cash flow from operations.
- MDA had positive earnings in 4 of the past 5 years.
- MDA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- MDA has a Return On Assets of 3.15%. This is in the lower half of the industry: MDA underperforms 69.23% of its industry peers.
- MDA has a Return On Equity of 8.24%. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
- MDA has a worse Return On Invested Capital (5.12%) than 61.54% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for MDA is significantly below the industry average of 9.34%.
- The last Return On Invested Capital (5.12%) for MDA is above the 3 year average (3.99%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
- MDA has a Profit Margin (7.40%) which is comparable to the rest of the industry.
- In the last couple of years the Profit Margin of MDA has grown nicely.
- With a Operating Margin value of 9.86%, MDA is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
- In the last couple of years the Operating Margin of MDA has grown nicely.
- MDA's Gross Margin of 24.62% is fine compared to the rest of the industry. MDA outperforms 69.23% of its industry peers.
- MDA's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MDA is destroying value.
- The number of shares outstanding for MDA has been increased compared to 1 year ago.
- MDA has a better debt/assets ratio than last year.
2.2 Solvency
- MDA has an Altman-Z score of 1.83. This is not the best score and indicates that MDA is in the grey zone with still only limited risk for bankruptcy at the moment.
- MDA has a better Altman-Z score (1.83) than 84.62% of its industry peers.
- The Debt to FCF ratio of MDA is 0.92, which is an excellent value as it means it would take MDA, only 0.92 years of fcf income to pay off all of its debts.
- MDA has a Debt to FCF ratio of 0.92. This is amongst the best in the industry. MDA outperforms 100.00% of its industry peers.
- A Debt/Equity ratio of 0.31 indicates that MDA is not too dependend on debt financing.
- MDA has a Debt to Equity ratio of 0.31. This is amongst the best in the industry. MDA outperforms 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.83 |
ROIC/WACC0.57
WACC9.04%
2.3 Liquidity
- MDA has a Current Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.55, MDA is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
- MDA has a Quick Ratio of 0.55. This is a bad value and indicates that MDA is not financially healthy enough and could expect problems in meeting its short term obligations.
- MDA has a Quick ratio (0.54) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
- MDA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.25%, which is quite impressive.
- MDA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 185.75% yearly.
- The Revenue has grown by 57.77% in the past year. This is a very strong growth!
- The Revenue has been growing by 31.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
- Based on estimates for the next years, MDA will show a very strong growth in Earnings Per Share. The EPS will grow by 35.72% on average per year.
- MDA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.84% yearly.
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 34.94, the valuation of MDA can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of MDA indicates a slightly more expensive valuation: MDA is more expensive than 69.23% of the companies listed in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.11. MDA is valued slightly more expensive when compared to this.
- The Price/Forward Earnings ratio is 25.55, which means the current valuation is very expensive for MDA.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of MDA is on the same level as its industry peers.
- When comparing the Price/Forward Earnings ratio of MDA to the average of the S&P500 Index (28.13), we can say MDA is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.94 | ||
| Fwd PE | 25.55 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, MDA is valued a bit more expensive than the industry average as 69.23% of the companies are valued more cheaply.
- Based on the Price/Free Cash Flow ratio, MDA is valued a bit cheaper than the industry average as 61.54% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.69 | ||
| EV/EBITDA | 19.73 |
4.3 Compensation for Growth
- MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- MDA's earnings are expected to grow with 35.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.33
PEG (5Y)N/A
EPS Next 2Y48.58%
EPS Next 3Y35.72%
5. Dividend
5.1 Amount
- MDA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:MDA (2/26/2026, 7:00:00 PM)
39.48
+0.62 (+1.6%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-14 2025-11-14/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners39%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap4.99B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts80
Price Target46.98 (19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)15.3%
PT rev (3m)14.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.43%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.04%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.94 | ||
| Fwd PE | 25.55 | ||
| P/S | 3.37 | ||
| P/FCF | 10.69 | ||
| P/OCF | 6.78 | ||
| P/B | 3.75 | ||
| P/tB | N/A | ||
| EV/EBITDA | 19.73 |
EPS(TTM)1.13
EY2.86%
EPS(NY)1.55
Fwd EY3.91%
FCF(TTM)3.69
FCFY9.35%
OCF(TTM)5.82
OCFY14.75%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.33
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.83 |
F-Score6
WACC9.04%
ROIC/WACC0.57
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y105.61%
EPS Next 2Y48.58%
EPS Next 3Y35.72%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.84%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.32%
EBIT Next 3Y52.1%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 5 / 10 to MDA.CA.
Can you provide the valuation status for MDA SPACE LTD?
ChartMill assigns a valuation rating of 4 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 5 / 10.
What is the financial health of MDA SPACE LTD (MDA.CA) stock?
The financial health rating of MDA SPACE LTD (MDA.CA) is 5 / 10.
What is the earnings growth outlook for MDA SPACE LTD?
The Earnings per Share (EPS) of MDA SPACE LTD (MDA.CA) is expected to grow by 105.61% in the next year.